Dereck Davis
Pediatrics · Jackson, MSNPI 1174567580
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,688 of the $19,755 with a category attached, or 79.4%. Vertex accounts for 69.2% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2023 at $8,942 and has fallen 94.9% since, to $459 in 2025. Among pediatrics clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $164.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$14K
- Sobi, Inc$3K
- Novartis$523
- Jazz Pharmaceuticals Inc.$376
- Sanofi-aventis U.S. LLC$289
- Pfizer$282
- plus $2K from 29 others
Across 8 payments — averaging $18,326 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$125K
- Dova Pharmaceuticals$14K
- National Marrow Donor Program$6K
- Novartis$2K
What the payments were for
- Consulting fees$15,68879%
- Travel & lodging$2531%
- Food & beverage$3,81419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 5 | $13,667 |
| Sobi, Inc | 6 | $2,694 |
| Novartis | 12 | $523 |
| Jazz Pharmaceuticals Inc. | 12 | $376 |
| Sanofi-aventis U.S. LLC | 4 | $289 |
| Pfizer | 13 | $282 |
| National Marrow Donor Program | 1 | $215 |
| Agios Pharmaceuticals, Inc. | 3 | $161 |
| CSL Behring | 3 | $132 |
| Amgen | 6 | $131 |
| Y-mabs Therapeutics, Inc. | 2 | $114 |
| Gilead | 1 | $97 |
| Emmaus Medical, Inc. | 5 | $88 |
| Servier Pharmaceuticals LLC | 7 | $87 |
| Bioverativ Therapeutics Inc. | 1 | $84 |
| Merck | 4 | $84 |
| Global Blood Therapeutics, Inc. | 5 | $81 |
| Mesoblast, Inc. | 1 | $80 |
| Novo Nordisk | 4 | $79 |
| RARE Disease Therapeutics, Inc. | 3 | $67 |
| Chiesi USA, Inc. | 2 | $57 |
| Puma Biotechnology, Inc. | 4 | $55 |
| AstraZeneca | 2 | $43 |
| Adaptive Biotechnologies Corporation | 1 | $35 |
| Grifols USA, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Teleflex LLC | 1 | $26 |
| HEMA Biologics, LLC | 1 | $23 |
| Bristol Myers Squibb | 1 | $21 |
| Genetix Biotherapeutics Inc | 1 | $19 |
| USWM, LLC | 1 | $19 |
| Day One Biopharmaceuticals | 1 | $17 |
| Bayer | 1 | $17 |
| ADMA Biomanufacturing LLC | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,755 in reported general payments places this provider in the 95th percentile of 419 pediatrics providers in Mississippi.
Other pediatrics in Jackson
- Tami BrooksJackson$14K
- Amanda PennyJackson$3K
- Kristie RohmanJackson$3K
- Joanna StoreyJackson$3K
- Katherine PatrickJackson$2K
- Jessica PerkinsJackson$2K
- Thomas IrelandTupelo$11K
- Denise PowellBay St Louis$7K
- Madelena CampbellGulfport$6K
- Angela OstrowskiGulfport$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.